A.M.L. spectacle lenses for children with myopia
Official title: An Evaluation of Visual Comfort, Adaptation and Overall Satisfaction in Myopic Children Using A.M.L. Series of Lenses
Run by Essilor International · NCT07354945 · Data updated 2026-11-12
We will try A.M.L. spectacle lenses in 6- to 12-year-old children with myopia to see how quickly they adapt and how comfortable the lenses feel.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 6 Years to 12 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Essilor International Industry-sponsored |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | January 2, 2026 |
| Main results expected | February 25, 2026 |
| Study ends | April 27, 2026 |
| Registry record updated | January 23, 2026 |
| Trial ID | NCT07354945 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 6 to 12 years with cycloplegic spherical equivalent between −0.50 D and −4.75 D, astigmatism ≤2.00 D, anisometropia ≤1.50 D, best-corrected visual acuity ≥ +0.10 LogMAR in each eye, good general health, and parental consent/child assent are eligible.
✕Probably not a fit
Children with higher myopia outside the specified range, significant astigmatism, amblyopia, strabismus, prior atropine/orthokeratology/red-light treatment, or other ocular/systemic conditions affecting refraction are unlikely to benefit from this specific test.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-arm, prospective interventional study enrolling 40 myopic children aged 6–12 years who will wear the A.M.L. series spectacle lenses for two weeks. Participants will be seen at day 4–6, week 1, and week 2 to record adaptation, wearing comfort, visual quality, and user satisfaction. Eligibility requires cycloplegic spherical equivalent between −0.50 D and −4.75 D, astigmatism ≤2.00 D, anisometropia ≤1.50 D, and best-corrected visual acuity ≥ +0.10 LogMAR in each eye. The study aims to document how many children adapt within 4–6 days and to characterize short-term wearing experience with these microlens-design myopia-control spectacles.
Why it matters
Potential benefit: If successful, these lenses could make spectacles more comfortable and easier for children with myopia to wear, potentially improving daily vision and adherence to correction.
How similar studies have gone: Other spectacle lenses using optical-defocus microlens designs have shown efficacy in slowing myopia and prior adaptation studies exist, but there are no published data specifically on the A.M.L. series.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Volunteer participant * Informed consent of parent/guardian and assent of participant * Age equal to or greater than 6 years and not older than 12 years at the time of signing informed consent and assent * Spherical equivalent refraction (SER) by cycloplegic autorefraction equal or less than -0.50 D and equal or greater than -4.75D with astigmatism not more than 2.00 D on both eye * Difference in SER (anisometropia) between two eyes should not exceed 1.50 D * Best corrected visual acuity (BCVA) better than or equal to +0.10 LogMAR in each eye * Be in good general health, based on the participant and the parent's/guardian's knowledge * Willingness and ability to participate in study and comply with all scheduled visits Exclusion Criteria: * History of Atropine, Orthokeratology, or Red Light treatment * Strabismus by cover test at near or distance wearing correction * Amblyopia * Any ocular or systemic condition known to affect refractive status (e.g. keratoconus, diabetes, Downs syndrome, or other developmental disorders, etc.) * Current use of ocular or systemic medications which, in the investigator's opinion, may significantly affect pupil size, accommodation or refractive state * History of ocular injury or surgery * Participation in any clinical study within 30 days of the Baseline visit * Study participants deemed inappropriate for the study by the investigator * The inherent ocular/systemic discomfort (dry eyes, visual fatigue, headaches, etc.) that may affect the evaluation of the study lens wearing experience, from the investigator's perspective
Where it's running
-
Shanghai Meishimeijing Ophthalmology Clinic Co., Ltd.
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Jiaoyan DU
- Email: du.jiaoyan@essilorchina.com
- Phone: 86+17696115308
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating a device for screening vision problems in young children
This study is testing a new device to see if it can effectively find vision problems in children aged 3 to 8, whether they wear glasses or not.
-
Optimizing light exposure to prevent and control myopia in children
This study tests if changing classroom lighting to mimic sunlight or using a smartphone app to guide light exposure can help prevent and control myopia in primary school children.
-
Choroidal thickness change after 1 hour wearing prototype soft contact lenses
This test will see if three prototype soft contact lenses change choroidal thickness in people aged 18 to 25 with myopia.
-
Optimizing SMILE surgery for correcting vision problems
This study is testing if using a new system for SMILE eye surgery can help patients see better after the procedure compared to the traditional method.
-
Hyperopic reserve screening for kindergartners in Beijing
A population-wide screening tests whether senior kindergarten children in Beijing have enough hyperopic reserve to help prevent future myopia.
-
Do dual-focus multifocal contact lenses improve hand-eye coordination and sports vision compared with your usual lenses
This study tests whether wearing dual-focus multifocal contact lenses improves hand-eye coordination and sports vision in adults who play baseball or softball and normally wear contact lenses.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.